Immunotherapy, checkpoint inhibitor advance to frontline non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/12238
Abstract: For many years, immune-based therapies have been explored in a selected array of cancers traditionally considered “immunogenic”, namely melanoma, prostate, renal cell, non-Hodgkin’s lymphoma, bladder cancer, and renal cell carcinoma. Until recently, lung cancer has… read more here.
Keywords: inhibitor advance; immunotherapy checkpoint; lung cancer; cancer ... See more keywords